BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Giang L, Selinger CP, Lee AU. Evaluation of adherence to oral antiviral hepatitis B treatment using structured questionnaires. World J Hepatol 2012; 4(2): 43-49 [PMID: 22400085 DOI: 10.4254/wjh.v4.i2.43]
URL: https://www.wjgnet.com/1948-5182/full/v4/i2/43.htm
Number Citing Articles
1
Dilip Ratnam, Peter Angus. Global Perspectives: Australia – Real World Experience with HBV Antiviral TherapyCurrent Hepatitis Reports 2012; 11(4): 213 doi: 10.1007/s11901-012-0152-4
2
Mayank Jain, Sagar Adkar, Chandrashekhar Waghmare. Adherence to oral antivirals in patients with chronic hepatitis B infectionIndian Journal of Gastroenterology 2014; 33(4): 390 doi: 10.1007/s12664-013-0433-z
3
Spilios Manolakopoulos, Athanasia Striki, Vasilios Papastergiou, Nikoleta Perlepe, Konstantinos Zisimopoulos, Afroditi Papazoglou, Melanie Deutsch, Nikolaos Papadopoulos, Christos Triantos, John Goulis, George Papatheodoridis. Persistence and adherence to nucleos(t)ide analogues in chronic hepatitis B: a multicenter cohort studyEuropean Journal of Gastroenterology & Hepatology 2020; 32(5): 635 doi: 10.1097/MEG.0000000000001558
4
Suzanne Polis, Iryna Zablotska-Manos, Amany Zekry, Lisa Maher. Adherence to Hepatitis B Antiviral TherapyGastroenterology Nursing 2017; 40(3): 239 doi: 10.1097/SGA.0000000000000161
5
Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen, James Fung. Chronic hepatitis B: a scoping review on the guidelines for stopping nucleos(t)ide analogue therapyExpert Review of Gastroenterology & Hepatology 2023; 17(5): 443 doi: 10.1080/17474124.2023.2196405
6
Yuri Cho, SeongBeom Park, SeonYoung Park, WonJung Choi, Book Kim, Helin Han. Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South KoreaInfectious Diseases and Therapy 2023; 12(10): 2387 doi: 10.1007/s40121-023-00860-8
7
Nathan Ford, Roz Scourse, Maud Lemoine, Yvan Hutin, Marc Bulterys, Zara Shubber, Dmytro Donchuk, Gilles Wandeler. Adherence to Nucleos(t)ide Analogue Therapies for Chronic Hepatitis B Infection: A Systematic Review and Meta‐AnalysisHepatology Communications 2018; 2(10): 1160 doi: 10.1002/hep4.1247
8
Jolynne Mokaya, Anna L. McNaughton, Phillip A Bester, Dominique Goedhals, Eleanor Barnes, Brian D Marsden, Philippa C. Matthews. Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanismsWellcome Open Research 2020; 5: 151 doi: 10.12688/wellcomeopenres.15992.1
9
Hirofumi Go, Makoto Tanaka, Noriko Yamamoto-Mitani, Miho Suzuki, Aki Kawakami, Naohiko Masaki, Megumi Shimada. Medication Adherence Among Patients With Chronic Hepatitis Receiving Antiviral TreatmentGastroenterology Nursing 2019; 42(2): 140 doi: 10.1097/SGA.0000000000000363
10
Christian P. Selinger, Andrew Robinson. The Handbook of Behavioral Medicine2014; : 23 doi: 10.1002/9781118453940.ch2
11
Suzanne Sheppard-Law, Iryna Zablotska-Manos, Melissa Kermeen, Susan Holdaway, Alice Lee, Jacob George, Amany Zekry, Lisa Maher. Factors Associated with Non-Adherence to HBV Antiviral TherapyAntiviral Therapy 2018; 23(5): 425 doi: 10.3851/IMP3219
12
Benedetto Caroleo, Orietta Staltari, Luca Gallelli, Francesco Perticone. Reactivation of chronic hepatitis B during treatment with tenofovir disoproxil fumarate: drug interactions or low adherence?: Table 1BMJ Case Reports 2015; : bcr2015209586 doi: 10.1136/bcr-2015-209586
13
Suzanne Sheppard-Law, Iryna Zablotska-Manos, Melissa Kermeen, Susan Holdaway, Alice Lee, Amany Zekry, Gregory J Dore, Jacob George, Lisa Maher. Factors associated with HBV Virological BreakthroughAntiviral Therapy 2017; 22(1): 53 doi: 10.3851/IMP3087
14
H. Chi, A. Japhary, R. A. de Man, R. J. de Knegt, H. L. A. Janssen, B. E. Hansen. Younger age and language barriers are associated with nonadherence to clinical follow‐up in hepatitis B treatmentJournal of Viral Hepatitis 2018; 25(10): 1216 doi: 10.1111/jvh.12920
15
Yueyue Li, Anni Chen, Hui Wang, Lu Han, Rong Wang, Guoqing Zhang, Yongfang Yuan. Treatment Adherence to Nucleos(t)ide Analogs in Chinese Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma: A Single-Center Cross-Sectional StudyPatient Preference and Adherence 2021; : 1729 doi: 10.2147/PPA.S317250
16
Ling-Na Kong, Ying Guo, Bo Qin, Xin Peng, Wen-Fen Zhu, Mario U. Mondelli. Development of Self-Management Indicators for Chronic Hepatitis B Patients on Antiviral Therapy: Results of a Chinese Delphi Panel SurveyPLOS ONE 2015; 10(9): e0134125 doi: 10.1371/journal.pone.0134125
17
Rodrigo M Abreu, Leda C Bassit, Sijia Tao, Yong Jiang, Aline S Ferreira, Patrícia CA Hori, Lilia M Ganova-Raeva, Yury Khudyakov, Raymond F Schinazi, Flair J Carrilho, Suzane K Ono. Long-term Virological and Adherence Outcomes to Antiviral Treatment in a 4-year Cohort Chronic HBV StudyAntiviral Therapy 2019; 24(8): 567 doi: 10.3851/IMP3338
18
N. Allard, A. Dev, J. Dwyer, G. Srivatsa, A. Thompson, B. Cowie. Factors associated with poor adherence to antiviral treatment for hepatitis BJournal of Viral Hepatitis 2017; 24(1): 53 doi: 10.1111/jvh.12582
19
Faydra I. Lieveld, Lotte G. van Vlerken, Peter D. Siersema, Karel J van Erpecum. Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic reviewAnnals of Hepatology 2013; 12(3): 380 doi: 10.1016/S1665-2681(19)31000-2
20
Kerui Xu, Li-Ming Liu, Paraskevi A. Farazi, Hongmei Wang, Fedja A Rochling, Shinobu Watanabe-Galloway, Jian-Jun Zhang. Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis BGlobal Health Action 2018; 11(1): 1433987 doi: 10.1080/16549716.2018.1433987
21
Zahra Taheri Ezbarami, Parkhideh Hassani, Mansoureh Zagheri Tafreshi, Hamid Alavi Majd. A qualitative study on individual experiences of chronic hepatitis B patientsNursing Open 2017; 4(4): 310 doi: 10.1002/nop2.100
22
Marco Vincenzo Lenti, Christian P. Selinger. Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventionsExpert Review of Gastroenterology & Hepatology 2017; : 1 doi: 10.1080/17474124.2017.1284587
23
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman StatementsJournal of Clinical and Experimental Hepatology 2018; 8(1): 58 doi: 10.1016/j.jceh.2017.12.001